MOH — authorised 18 January 2008
- Marketing authorisation holder: JANSSEN R AND D
- Status: likely_approved
MOH authorised Intelence on 18 January 2008
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 18 January 2008.
JANSSEN R AND D holds the UAE marketing authorisation.